Pneumococcal Polysaccharide Vaccination in Pediatric Inflammatory Bowel Disease
According to current recommendations, in addition to 13-valent pneumococcal conjugate vaccine (PCV13) series, all children with inflammatory bowel disease (IBD) aged ≥2 years, with planned or current immunosuppression, should receive pneumococcal polysaccharide vaccine (PPSV23). The primary aim was...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2019-05-01
|
| Series: | Global Pediatric Health |
| Online Access: | https://doi.org/10.1177/2333794X19849754 |